When glycaemic measurements do not reach targets, and insulin is the best choice for the individual, its introduction should not be delayed
Increasing the milligrams changes the balance among GIP, GLP-1, and glucagon rather than turning up one uniform effect
From what I have seen and experienced, many people notice measurable weight loss within the first three months, especially once they reach a stable dose
Researchers should interpret the cited literature within the experimental context of each individual study
This is due to several factors that differ between the controlled conditions of in vitro studies and the complex biological processes in living organisms, including interactions between different cell types, organ systems, and environmental variables (e.g., gut microbiota or circulation) that can influence how a drug works
Precision matters